Volume 209 - Issue 10

Health protection and Australian prisons, 2018

Authors:  Michael H Levy and Carla J Treloar

Med J Aust 2018; 209 (10): 460-461. || doi: 10.5694/mja18.00669
Published online: 19 November 2018

To the Editor:

In 2007 and again in 2012, we highlighted in the Medical Journal of Australia1,2 the limited access Australian prisoners had to essential health protection measures. Six years on, we can only report that progress has been minimal (Box).

In August 2012, the Australian Capital Territory Chief Minister announced the implementation of a needle exchange program for prisoners in the ACT; 6 years later, the ACT government retracted its commitment. Canada has recently agreed to a pilot prison-based needle exchange, with a commitment to national implementation in 2019.

Human immunodeficiency virus (HIV) is still not a concern in Australian prisons, although bleach provision and condoms are still severely restricted in Queensland and the Northern Territory, and effectively not available in Victoria and Tasmania. Hepatitis B immunisation coverage continues to improve, and chronic hepatitis B infection is not increasing among Aboriginal and Torres Strait Islander prisoners.3

The availability of direct-acting antiviral treatments for hepatitis C infection for all Australians, including prisoners, has some Australian prisons already reporting treatment achievements commensurate to international treatment targets for 20304 — the term “micro-elimination” has been applied to facility by facility reduction of burden of this infection. However, despite reductions in hepatitis C in Australian prisons, the risk of transmission is ever present.5

The predictors of successful return to the community include housing, employment and maintenance of relationships;6 yet, private family (conjugal) visits are only allowed in some Victorian prisons and in one South Australian prison farm. Visits are definitely not available to ACT prisoners, since previous enabling policy was repealed in 2014. Safer sex is still an elusive aspiration for the majority of Australian prisoners and their families.

Tattoo and body piercing programs are being implemented in prisons in Luxembourg and Catalonia, Spain. Despite this activity being successfully regulated in the community, there are still no verifiable reports of sanctioned programs in Australian prisons.

In 2012, we questioned Australia’s commitment to protecting the health of prisoners.2 With changes in prison harm reduction programs internationally (notably, Canada) underpinned by legal challenges, we foresee that similar proceedings could have a place in finally driving reform in Australia.

Box – Progress in Australian prisoners’ access to essential health protection measures

Jurisdiction

Changes since 2012


Australian Capital Territory

Bleach available in single unit sachets; micro-elimination of hepatitis C from the only prison; private family visits ceased; support for a prison needle exchange program withdrawn

New South Wales

Micro-elimination of hepatitis C from several prisons

Northern Territory

No notable changes

Queensland

Still considering opiate replacement therapy; micro-elimination of hepatitis C from one prison

South Australia

Private visits available at one prison farm

Tasmania

Micro-elimination of hepatitis C from one prison

Victoria

Micro-elimination of hepatitis C from several prisons

Western Australia

Poor uptake of hepatitis C treatment


 


Authors


Competing interests


References